Notably, IFN-γR−/− and Prf−/− mice showed significantly rescued NAFLD symptoms, including diminished hepatic steatosis, cellular ballooning, and lipid accumulation (Figure 6C). Here, IFNGR1 is linked to metabolic dysfunction-associated steatotic liver disease.